tiprankstipranks
Advertisement
Advertisement
RXO: Near-Term Earnings Pressure but Emerging 2026 Recovery Supports Hold Rating
PremiumRatingsRXO: Near-Term Earnings Pressure but Emerging 2026 Recovery Supports Hold Rating
1M ago
RXO Inc. management to meet with Truist
Premium
The Fly
RXO Inc. management to meet with Truist
1M ago
RXO Inc. price target raised to $17 from $15 at Barclays
Premium
The Fly
RXO Inc. price target raised to $17 from $15 at Barclays
2M ago
RXO Plans $400 Million Senior Notes to Refinance Debt
PremiumCompany AnnouncementsRXO Plans $400 Million Senior Notes to Refinance Debt
3M ago
RXO Earnings Call Balances Margin Pain and Pipeline Gains
Premium
Company Announcements
RXO Earnings Call Balances Margin Pain and Pipeline Gains
3M ago
RXO Inc. price target raised to $15 from $13 at Stephens
Premium
The Fly
RXO Inc. price target raised to $15 from $13 at Stephens
3M ago
RXO Inc. price target lowered to $14 from $15 at JPMorgan
PremiumThe FlyRXO Inc. price target lowered to $14 from $15 at JPMorgan
3M ago
RXO Inc. price target raised to $17 from $16 at BofA
Premium
The Fly
RXO Inc. price target raised to $17 from $16 at BofA
3M ago
RXO Inc. price target raised to $17 from $15 at UBS
Premium
The Fly
RXO Inc. price target raised to $17 from $15 at UBS
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100